Researchers seeking to improve treatment outcomes for women with recurrent endometrial cancer – the most commonly diagnosed gynecologic malignancy in the U.S., killing more than 8,000 women each year – have reported positive results through targeted therapy that uses a combination of the drugs everolimus and letrozole. Their findings have been reported in the Journal of Clinical Oncology.
Comprehensive care for womenGynecology
We deliver more than 4,000 babies a yearUDeliver
Less invasive surgery for womenFind out more
Practitioners from all over the world gathered last week at the Fontainebleau Miami Beach for the 38th annual Miami Neonatology conference, sponsored by the Miller School of Medicine and presented by the Department of Pediatrics’ Division of Neonatology. This year’s theme, “Advances in Respiratory Care,” featured two dozen of the field’s leading experts sharing the latest research and clinical knowledge.